The Centers for Medicare & Medicaid Services (CMS) issued a final rule that includes updates on policy changes for Medicare payments under the Physician Fee Schedule (PFS), and other Medicare Part B issues, on or after January 1, 2022.
CMS Releases Billing Codes for J&J and Moderna Boosters
The Centers for Medicare & Medicaid Services (CMS) released Medicare Part B billing codes and payment allowances for reporting and administering single booster doses of Johnson & Johnson and Moderna COVID-19 vaccines to eligible adults as authorized by the Food and Drug Administration (FDA) on October 20, 2021.
CMS Issues Guidance On Required Medicaid & CHIP COVID-19 Coverage
The Centers for Medicare & Medicaid Services (CMS) issued guidance on Medicaid and Children’s Health Insurance Program (CHIP) coverage of COVID-19-related treatment under the American Rescue Plan Act of 2021 (ARP).
AMA Announces CPT Codes for Pfizer’s Pediatric COVID-19 Doses
The American Medical Association (AMA) issued new Current Procedural Terminology (CPT) vaccine and administration codes for pediatric doses of the COVID-19 vaccine developed by Pfizer. The provisional codes will be effective for use if Pfizer’s two-dose COVID-19 vaccine for children ages 5 to 11 receives U.S. Food and Drug Administration (FDA) approval or emergency use authorization.
GAO Reports On Provider Performance And Experiences Under MIPS
The Centers for Medicare & Medicaid Services (CMS) administers the Merit-based Incentive Payment System (MIPS), under which MIPS-eligible providers receive a “final score” based on their performance on four measures (quality, cost, promoting interoperability and improvement activities). Their score is compared to a performance threshold, following which, providers receive a negative, neutral, or positive payment adjustment applied to future Medicare payments.
